Legal & General Group
AKCA

Legal & General Group’s Akcea Therapeutics Inc AKCA Stock Holding History

Legal & General Group’s Portfolio AKCA Stock Details AKCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,017
Closed -$36K – 3523
2020
Q3 		$36K Sell
2,017
-699
-26% -$9.92K ﹤0.01% 2795
2020
Q2 		$38K Buy
2,716
+257
+10% +$3.96K ﹤0.01% 2811
2020
Q1 		$35K Sell
2,459
-433
-15% -$7.11K ﹤0.01% 2716
2019
Q4 		$49K Buy
2,892
+463
+19% +$8.62K ﹤0.01% 2822
2019
Q3 		$37K Hold
2,429
– – ﹤0.01% 2875
2019
Q2 		$57K Hold
2,429
– – ﹤0.01% 2722
2019
Q1 		$69K Buy
2,429
+192
+9% +$5.59K ﹤0.01% 2614
2018
Q4 		$67K Hold
2,237
– – ﹤0.01% 2588
2018
Q3 		$79K Buy
2,237
+338
+18% +$10.2K ﹤0.01% 2576
2018
Q2 		$45K Sell
1,899
-806
-30% -$19.2K ﹤0.01% 2801
2018
Q1 		$69K Sell
2,705
-1,271
-32% -$27.4K ﹤0.01% 2615
2017
Q4 		$70K Hold
3,976
– – ﹤0.01% 2751
2017
Q3 		$111K Buy
+3,976
New +$73.6K ﹤0.01% 2592

Legal & General Group's AKCA Position: Q4 2020 in Review

Legal & General Group sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 2,017 shares — an estimated $36K sold.

Legal & General Group first reported a position in AKCA in Q3 2017 and held it in 13 quarters. The position peaked at $111K in Q3 2017. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

  • Legal & General Group reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
  • Legal & General Group sold 2,017 Akcea Therapeutics Inc shares in Q4 2020, an estimated $36K.
  • Legal & General Group first reported a position in Akcea Therapeutics Inc in Q3 2017 and held it in 13 quarters.
  • Legal & General Group's Akcea Therapeutics Inc position peaked at $111K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Legal & General Group's 13F filing for Q4 2020, filed 12 Feb 2021.